- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03142269
The Influences Of Anterior Capsule Polishing On Anterior Capsular Changes and Intraocular Lenses Stability of Super High Myopic Eyes
May 2, 2017 updated by: yin ying zhao
The Influences of 360° Anterior Capsule Polishing on Refraction, Anterior Capsular Opening Size and IOL Stability Among Super High Myopia Patients
A prospective study included 20 patients with super high myopia who underwent bilateral uneventful cataract.
360°anterior capsule polishing was performed with double-ended capsule polisher randomly in one eye, and the opposite unpolished was used as the control.
The refractive state and size of anterior opening were measured at postoperative 1 day as the baseline.
Then they followed up at 1 month, 3 months and 6 months after surgery to record refractive state, higher-order aberrations, size of anterior opening, tilt and decentration of IOL (intraocular lenses)and PAD(postoperative aqueous depth).
The paired t test was used to compare the differences between the two groups, and the same test the postoperative follow-up comparing with the baseline.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:cataract patients with super high myopia (axial length >27mm) and difference of binocular was less than 1mm Exclusion Criteria:larger corneal astigmatism need toric intraocular lens; patients with any systemic or ocular diseases that may influence the anterior capsule opening morphologic, such as keratonosus, glaucoma, uveitis, Pseudoexfoliation syndrome, retinitis pigmentosa and diabetes and Myotonic Dystrophy, etc.; patients with ophthalmic surgery and trauma history.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: polished group
360°anterior capsule polishing was performed with double-ended capsule polisher randomly in one eye
|
360°anterior capsule polishing was performed with double-ended capsule polisher
|
Placebo Comparator: unpolished group
the opposite unpolished was used as the control
|
360°anterior capsule polishing was performed with double-ended capsule polisher
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
refraction
Time Frame: Change from postoperative 1 day to 1 months
|
refractive state
|
Change from postoperative 1 day to 1 months
|
anterior opening size
Time Frame: Change from postoperative 1 day to 1 months
|
area,diameter
|
Change from postoperative 1 day to 1 months
|
Stability of IOL
Time Frame: Change from postoperative 1 months to 3 months
|
Tilt and Decentration
|
Change from postoperative 1 months to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
refraction
Time Frame: Change from postoperative 1 month to 3 months
|
refractive state
|
Change from postoperative 1 month to 3 months
|
refraction
Time Frame: Change from postoperative 3 month to 6 months
|
refractive state
|
Change from postoperative 3 month to 6 months
|
anterior opening size
Time Frame: Change from postoperative 1 month to 3 months
|
area,diameter
|
Change from postoperative 1 month to 3 months
|
anterior opening size
Time Frame: Change from postoperative 3 month to 6 months
|
area,diameter
|
Change from postoperative 3 month to 6 months
|
Stability of IOL
Time Frame: Change from postoperative 3 month to 6 months
|
Tilt and Decentration
|
Change from postoperative 3 month to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 31, 2016
Study Registration Dates
First Submitted
February 25, 2017
First Submitted That Met QC Criteria
May 2, 2017
First Posted (Actual)
May 5, 2017
Study Record Updates
Last Update Posted (Actual)
May 5, 2017
Last Update Submitted That Met QC Criteria
May 2, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- kyk201601
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia, High, With Cataract and Anterior Capsule Polished
-
Wenzhou Medical UniversityNot yet recruitingCapsular Tension Ring | High MyopiaChina
-
Wenzhou Medical UniversityNot yet recruiting
-
Yune ZhaoRecruitingHigh Myopia | Low Intraocular PressureChina
-
University of Occupational and Environmental HealthUnknownCataract With Exfoliation SyndromeJapan
-
Shanghai High Myopia Study GroupEye & ENT Hospital of Fudan UniversityRecruiting
-
Afyon Kocatepe University HospitalCompletedRetinal Degeneration | Macula Edema | Retinal Detachment | Posterior Capsule Opacification | Macular Pigmentation | Choroid Disease | Anterior Chamber Angle Congestion
-
Shanghai Eye Disease Prevention and Treatment CenterBrien Holden VisionRecruitingBlindness,Visual Impairment, Refractive Error, Cataract, High Myopia, AgingChina
-
Samsung Medical CenterUnknownMacular Hole With High Myopia (Spherical Equivalent ≤ -6.0 Diopters) or, | Large Size Macular Hole (Diameter > 600 Microns) or | Recurred or Failed Macular Hole From Previous Surgery | or Chronic Macular Hole (Symptom Duration > 6 Months)Korea, Republic of
-
Children's Hospital of PhiladelphiaIllumina, Inc.Active, not recruitingMucopolysaccharidoses | Leukodystrophy | Adrenoleukodystrophy | Adrenomyeloneuropathy | X-linked Adrenoleukodystrophy | Gangliosidoses | Metachromatic Leukodystrophy | Krabbe Disease | Refsum Disease | Cadasil | Sjogren-Larsson Syndrome | Allan-Herndon-Dudley Syndrome | White Matter Disease | GM2 Gangliosidosis | Zellweger... and other conditionsUnited States
-
Children's Hospital of PhiladelphiaEli Lilly and Company; University of Pennsylvania; Takeda; National Institute of... and other collaboratorsRecruitingMucopolysaccharidoses | Leukoencephalopathies | Leukodystrophy | Adrenoleukodystrophy | Adrenomyeloneuropathy | X-linked Adrenoleukodystrophy | Gangliosidoses | Metachromatic Leukodystrophy | Krabbe Disease | Refsum Disease | Cadasil | Sjogren-Larsson Syndrome | Allan-Herndon-Dudley Syndrome | White Matter Disease | GM2... and other conditionsUnited States
Clinical Trials on 360°anterior capsule polishing
-
Shandong UniversityCompleted
-
Sun Yat-sen UniversityUnknownCataract | Posterior Capsule OpacificationChina
-
University of OxfordActive, not recruitingSevere Enduring Anorexia NervosaUnited Kingdom
-
Shahid Beheshti University of Medical SciencesActive, not recruitingGlaucoma | CataractIran, Islamic Republic of
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyBelgium, United Kingdom, Denmark, Finland, Sweden, Germany, Spain, Italy, Czech Republic, Netherlands
-
Simon Ducharme, MDAlzheimer's Drug Discovery FoundationActive, not recruitingFrontotemporal Dementia | Primary Progressive Aphasia | Frontotemporal Dementia, Behavioral Variant | FTD | PPA | bvFTDCanada
-
Sint MaartenskliniekCompletedArthroplasty, Replacement, KneeNetherlands
-
AbbottCompletedHuman Immunodeficiency Virus InfectionsUnited States, Australia, Belgium, Canada, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland, Taiwan, United Kingdom